Equities
Health CareMedical Equipment and Services
  • Price (AUD)20.35
  • Today's Change0.05 / 0.25%
  • Shares traded78.87k
  • 1 Year change-45.56%
  • Beta0.5541
Data delayed at least 20 minutes, as of Feb 16 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.

  • Revenue in NZD (TTM)14.41bn
  • Net income in NZD252.72m
  • Incorporated1922
  • Employees5.77k
  • Location
    EBOS Group LtdLevel 7, 737 Bourke Street, DocklandsCHRISTCHURCH 3008AustraliaAUS
  • Phone+61 39918-5555
  • Fax+61 39918-5599
  • Websitehttps://www.ebosgroup.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EBO:ASX since
announced
Transaction
value
Transmedic Pte LtdDeal completed10 Apr 202510 Apr 2025Deal completed-41.99%21.75m
Svs Veterinary Supplies LtdDeal completed28 Feb 202528 Feb 2025Deal completed-41.13%70.36m
Data delayed at least 20 minutes, as of Feb 16 2026 05:10 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.